Current Research Studies

AALL1231, A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)

AALL1231, A Phase III Randomized Trial Investigating Bortezo

  • Condition(s): Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Leukemia, other, Non-Hodgkin's Lymphoma
  • Phase: III
  • Clinicaltrials.gov ID: NCT02112916

What is the goal of the study?

To be submitted to PedCIRB.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: